Edgar Ben, Pearson Rob, Jackson Andrew, Stove Callum, Kasthuri Ram, Hussey Keith, Delles Christian, Geddes Colin, Mark Patrick, Roditi Giles, McCallum Linsay, Kingsmore David B
School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
Glasgow Renal and Transplant Unit, Queen Elizabeth University Hospital, Glasgow, UK.
Sci Rep. 2025 Jan 28;15(1):3475. doi: 10.1038/s41598-025-86663-y.
Renal ischaemia due to renal artery stenosis produces two differing responses - a juxtaglomerular hypertensive response and cortical renal dysfunction. The reversibility of renal impairment is not predictable, and thus renal revascularisation is controversial. This study aims to test the hypothesis that the hypertensive response to renal ischaemia reflects viable renal parenchyma, and thus could be used to predict the recovery in renal function. A retrospective analysis was performed of all patients who had renal revascularisation for renal impairment in a defined geographical area (West of Scotland, population 2.4 million) between 2008 and 2024. Clinical records were used to determine the pre-intervention blood pressure, anti-hypertensive medication load and renal function, and post-intervention outcomes. The Hypertensive Index (HTi), a combined measure of systolic blood pressure and antihypertensive drug load, was used as a measure of pre-intervention hypertensive response. 75 patients had intervention for renal impairment over 15 years (68 endovascular, 7 open). Mean pre-intervention serum creatinine of 323 µmol/L was reduced to 191 umol/L at discharge and 182 µmol/L at 6-month follow-up. Refractory hypertension (HTi > 120) was associated with a significant benefit from revascularisation with improved renal function (p = 0.003) and reduced risk of future dialysis (p = 0.001). Renal impairment with no hypertensive response was highly predictive of the need for future dialysis. The hypertensive index is a good predictor of the impact of renal revascularisation on improving renal function with good outcomes in selected patients, and the absence of this is an indicator of chronic non-reversible renal dysfunction.
肾动脉狭窄导致的肾缺血会产生两种不同的反应——肾小球旁器高血压反应和肾皮质功能障碍。肾功能损害的可逆性无法预测,因此肾血运重建存在争议。本研究旨在检验以下假设:对肾缺血的高血压反应反映了存活的肾实质,因此可用于预测肾功能的恢复。对2008年至2024年期间在特定地理区域(苏格兰西部,人口240万)因肾功能损害接受肾血运重建的所有患者进行了回顾性分析。利用临床记录确定干预前的血压、抗高血压药物负荷和肾功能以及干预后的结果。高血压指数(HTi),即收缩压和抗高血压药物负荷的综合指标,被用作干预前高血压反应的衡量标准。15年间有75例患者因肾功能损害接受了干预(68例为血管内介入,7例为开放手术)。干预前平均血清肌酐为323µmol/L,出院时降至191µmol/L,6个月随访时降至182µmol/L。难治性高血压(HTi>120)与血运重建带来的显著益处相关,包括肾功能改善(p=0.003)和未来透析风险降低(p=0.001)。无高血压反应的肾功能损害高度预示着未来需要透析。高血压指数是肾血运重建对改善肾功能影响的良好预测指标,对部分患者有良好效果,而缺乏这种反应则表明存在慢性不可逆肾功能障碍。